当前位置:首页 - 行情中心 - 天域生物(603717) - 财务分析 - 现金流量表

天域生物

(603717)

  

流通市值:19.21亿  总市值:19.21亿
流通股本:2.90亿   总股本:2.90亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金399,661,794.69199,143,976.43964,415,680.08655,625,079.61
  收到的税费返还101.29-152,238.3572,168.95
  收到其他与经营活动有关的现金26,099,863.7118,705,539.17136,103,258.57109,519,390.2
  经营活动现金流入小计425,761,759.69217,849,515.61,100,671,177765,216,638.76
  购买商品、接受劳务支付的现金337,937,550.3205,725,849.48629,568,533.74473,268,894.67
  支付给职工以及为职工支付的现金36,237,404.5719,390,709.2583,971,946.2959,617,446.42
  支付的各项税费8,056,437.471,799,582.516,472,654.156,690,899.25
  支付其他与经营活动有关的现金48,816,626.4532,302,878.61112,360,340.2178,427,861.59
  经营活动现金流出小计431,048,018.79259,219,019.84842,373,474.39618,005,101.93
  经营活动产生的现金流量净额-5,286,259.1-41,369,504.24258,297,702.61147,211,536.83
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额35,00035,000200,782.5423,825.54
  收到的其他与投资活动有关的现金46,875,718.4632,461,407.3312,535,404.981,535,404.98
  投资活动现金流入小计46,910,718.4632,496,407.3312,736,187.521,559,230.52
  购建固定资产、无形资产和其他长期资产支付的现金4,517,366.782,340,815.4353,479,070.8434,467,958.7
  投资支付的现金75,0007,415,0002,045,000-
  取得子公司及其他营业单位支付的现金7,540,000-60,509,397.5430,394,397.54
  支付其他与投资活动有关的现金43,535,00011,550,00019,660,650.094,160,650.09
  投资活动现金流出小计55,667,366.7821,305,815.43135,694,118.4769,023,006.33
  投资活动产生的现金流量净额-8,756,648.3211,190,591.9-122,957,930.95-67,463,775.81
三、筹资活动产生的现金流量:
  吸收投资收到的现金905,909.22890,000800,000800,000
  其中:子公司吸收少数股东投资收到的现金905,909.22890,000800,000800,000
  取得借款收到的现金39,760,969.0434,770,969.04115,926,150.4248,618,543.42
  收到其他与筹资活动有关的现金161,590,000135,000,000222,145,300156,300,000
  筹资活动现金流入小计202,256,878.26170,660,969.04338,871,450.42205,718,543.42
  偿还债务支付的现金32,010,566.861,978,571.41172,619,284.1466,704,344.89
  分配股利、利润或偿付利息支付的现金16,226,502.478,298,951.7350,055,246.8240,022,030.03
  支付其他与筹资活动有关的现金169,999,028.13146,262,613.88260,919,570.08200,398,190.18
  筹资活动现金流出小计218,236,097.46156,540,137.02483,594,101.04307,124,565.1
  筹资活动产生的现金流量净额-15,979,219.214,120,832.02-144,722,650.62-101,406,021.68
四、汇率变动对现金及现金等价物的影响-51,616.434,242.1657,484.872,474.66
五、现金及现金等价物净增加额-30,073,743.05-16,053,838.16-9,325,394.16-21,585,786
  加:期初现金及现金等价物余额90,941,798.1690,941,798.16100,267,192.32100,267,192.32
  期末现金及现金等价物余额60,868,055.1174,887,96090,941,798.1678,681,406.32
补充资料:
  净利润-51,610,011.63--102,015,606.15-
  资产减值准备11,370,262.87-22,928,085.66-
  固定资产和投资性房地产折旧24,625,517.47-40,598,027.29-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧24,625,517.47-40,598,027.29-
  无形资产摊销497,720.4-1,007,678.95-
  长期待摊费用摊销1,258,326.15-1,719,604.17-
  处置固定资产、无形资产和其他长期资产的损失56,646--25,973,538.27-
  固定资产报废损失1,459,433.21-1,849,051.35-
  公允价值变动损失3,184,605.53--8,633,602.76-
  财务费用24,999,173.75-53,680,430.16-
  投资损失-14,391,021.64-4,114,472.65-
  递延所得税-1,740,992.02-3,122,465.06-
  其中:递延所得税资产减少-1,627,328.3-3,354,407.6-
    递延所得税负债增加-113,663.72--231,942.54-
  存货的减少35,301,718.19-211,886,357.29-
  经营性应收项目的减少-24,870,452.27-60,730,663.36-
  经营性应付项目的增加-29,336,813.22--26,883,795.32-
  现金的期末余额60,868,055.11-90,941,798.16-
  减:现金的期初余额90,941,798.16-100,267,192.32-
  现金及现金等价物的净增加额-30,073,743.05--9,325,394.16-
公告日期2026-08-292026-04-302026-04-302025-10-30
审计意见(境内)标准无保留意见
TOP↑